Abstract
The review takes examples, mostly from the recent literature, to illustrate how an understanding of physico-chemical properties and an appreciation of the molecular shape and electronic properties can lead to a better insight into molecular recognition processes. The techniques used to generate 3-dimensional structures of molecules and the influence this information has had on the drug design cycle, are briefly discussed.
Similar content being viewed by others
References
Albers, M. W., Walsh, C. T., and Schreiber, S. L., Substrate specificity for the human rotamase FKBP: a view of FK506 and rapamysin as leucine-(twisted amide)-proline mimics. J. org. Chem.55 (1990) 4984–4986.
Allen, F. N., Bellard, S., Brice, M. D., Cartwright, B. A., Doubleday, A., Higgs, H., Hummellink, T., Hummellink-Peters, B. G., Kennard, O., Motherwell, W. D. S., Rogers, J. R., and Watson, D. G., The Cambridge crystallographic data centre: Computer-based search, retrieval analysis and display of information. Acta crystallogr.B35 (1979) 2331–2339.
Allinger, N. L., Molecular mechanics. J. Am. chem. Soc.99 (1977) 8127–8134.
Andrews, P. R., Craik, D. J., and Martin, J. L., Functional group contributions to drug-receptor interactions. J. med. Chem.27 (1984) 1648–1657.
Bash, P. A., Singh, U. C., Brown, F. K., Langridge, R., and Kollman, P. A., Calculation of the relative change in binding free energy of a protein-inhibitor complex. Science235 (1987) 574–576.
Bergin, R., and Carlstrom, D., The structure of catecholamines. II. The crystal structure of dopamine hydrochloride. Acta crystallogr.B24 (1968) 1506–1510.
Bernstein, F. C., Koetzel, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rogers, J. R., Kennard, O., Shimanouchi, T., and Tasumi, M., The Protein Databank: A computer based archival file for macromolecular structures. J. molec. Biol.112 (1977) 535–542.
Blaney, F., Molecular modelling in the pharmaceutical industry. Chemistry Industry (1990) 791–794.
Blaney, J. M., Weiner, P. K., Dearing, A., Kollman, P. A., Jorgensen, E. C., Oatley, S. J., Burridge, J. M., and Blake, C. C. F., Molecular mechanics simulation of protein-ligand interactions: Binding of thyroid hormone analogues to prealbumin. J. Am. chem. Soc.104 (1982) 6424–6434.
Blundell, T., Sibanda, B. L., and Pearl, L., Three-dimensional structure, specificity and catalytic mechanism of renin. Nature304 (1983) 273–275.
Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., and Hofsteege, J. The refined 1.9 Å crystal structure of human α-thrombin; interaction with D-Phe-Pro-Arg-chloromethylketone and significance of the Tyr-Pro-Pro insertion segment. EMBO J.8 (1989) 2467–2475.
Bode, W., Meyer, E., and Powers, J. C., Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanisms, substrate specificity and mechanism-based inhibitors. Biochemistry28 (1989) 1951–1963.
Bode, W., Tyrk, D., and Stuerzebecher, J., Geometry of binding of the benzamidine- and arginine- based inhibitors N-α-(2-naphthylsulphonylglycyl)DL-p-aminophenylalanylpiperidine (NAPAP) and (2R,4R)-4-methyl-1-(N-α-(3-methyl-1,2,3,4-tetrahydro-8-quinilinesulphonyl)-L-arginyl)-2-piperidine carboxylic acid (MQPA) to human α-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modelling of NAPAP-thrombin and MQPA-thrombin. Eur. J. Biochem.193 (1990) 175–182.
Burt, S. K., and Greer, J., Search strategies for determining bioactive conformers of peptides and small molecules. A. Rep. med. Chem.23 (1988) 285–294.
Clore, M. G., and Gronenborn, A. M., Structures of large proteins in solution three- and four-dimensional heteronuclear NMR spectroscopy. Science252 (1991) 1390–1399.
Cohen, C. N., Blaney, J. M., Humblet, C., Grund, P., and Barry, D. C., Molecular modeling software and methods for medicinal chemistry. J. med. Chem.33 (1990) 883–894.
Cooper, J. B., Foundling, S. I., Blundell, T. L., Boger, J., Jupp, R. A., and Kay, K., X-ray studies of aspartic proteinase-statin inhibitor complexes. Biochemistry28 (1989) 8596–9479.
Cramer, R. D., Patterson, D. E., and Bunce, J. D., Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J. Am. chem. Soc.110 (1988) 5959–5967.
Davis, J. F., Delcamp, T. J., Prendergast, N. J., Ashford, V. A., Freisheim, J. J., and Kraut, J., Crystal structure of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry29 (1990) 9467.
Dean, P. M., Drug-receptor recognition: Electrostatic field lines at the receptor and dielectric effects. Br. J. Pharmac.74 (1981) 39–46.
Derome, A. E., Modern NMR Techniques for Chemistry Research. Pergamon Press, Oxford 1987.
Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., and Stewart, J. J. P., AM1: A new general purpose quantum molecular model. J. Am. chem. Soc.107 (1985) 3902–3902.
Dewar, M. J. S., and Thiel, W. J., Ground state of molecules. 38. The MNDO approximations and parameters. J. Am. chem. Soc.99 (1977) 4899–4907.
van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L., and Clardy, J., Atomic structure of FKBP-FK506, an immunophilinimmunosuppressant complex. Science252 (1991) 839–842.
Ehrlich, P., On immunity with special reference to cell life. Croonian Lecture. Proc. Roy. Soc. London66 (1900) 424–428.
Erickson, J., Neidhardt, D. J., Van Drie, J., Krempf, D. J., Wang, X. C., Norbeck, D. W., Plattner, J. J., Rittenhouse, J. W., Turon, M., Wideburg, N., Kohlbrenner, W. E., Simmer, R., Helfrich, R., Paul, D. A., and Knigge, M., Design, activity, and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science249 (1990) 527–529.
Finkelstein, A. V., and Janin, J., The price of lost freedom: entropy of bimolecular complex formation. Protein Engng3 (1989) 1–3.
Fleischman, S. H., and Brooks, C. L., Protein drug interactions: Characterisation of inhibitor binding in complexes of DHFR with trimethoprim and related derivatives. Proteins7 (1990) 52–61.
Frisch, M. J., Head-Gordon, M., Trucks G. W., Foresman, J. B., Schlegel, H. B., Raghavachari, K., Robb, M. A., Binkley, J. S., Gonzlas, C., Defress, D. J., Fox, D. J., Whiteside, R. A., Seeger, R., Melius, C. F., Baker, J., Martin, R. L., Kahn, L. R., Stewart, J. J. P., Topiol, S., and Pople, J. A., Gaussian 90. Gaussian Inc, Pittsburg PA 1990.
Geller, M., Swanson, S. M., and Meyer, E. F. Jr, Dynamic properties of the first steps of enzymatic reaction steps of porcine pancreatic elastase (PPE). Molecular dynamics simulation of a Michaelis complex: PPE and hexapeptide Thr-Pro-n-Val-Leu-Tyr-Thr. J. Am. chem. Soc.112 (1990) 8925–8931.
Getzoff, E. D., Tainer, J. A., Weiner, P. K., Kollman, P. A., Richardson, J. S., and Richardson, D. C., Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature306 (1983) 287–290.
Grutter, M. G., Priestle, J. P., Rahuel, J., Grossenbacher, H., Bode, W., Hofsteege, J., and Stone, S. R., Crystal structure of the thrombinhirudin complex: a novel mode of serine protease inhibition. EMBO J.9 (1990) 2361–2365.
Gund, P., Halgren, T. A., and Smith, G. M., Molecular modeling as an aid to drug design and discovery. A. Rep.med. Chem.22 (1987) 269–279.
van Gunsteren, W. F., Methods for calculation of free energies and binding constants: Sucess and problems, in: Computer Simulations of Bimolecular Systems and Experimental Applications, pp. 27–59. Eds W. F. van Gunsteren and P. K. Weiner. ESCOM, 1989.
van Gunsteren, W. F., and Berendsen, H. J. C., Molecular Dynamics simulations: Techniques and applications to proteins, in: Molecular Mechanics and Protein Structure, pp. 5–14. Ed. J. Hermans. Polycrystal Books Service, Western Springs, Illinois, 1985.
van Gunsteren, W. F., and Berendsen, H. J. C., Thermodynamic cycle integration by computer simulation as a tool for obtaining free energy difference in molecular chemistry. J. comp.-aided molec. Design1 (1987) 171–179.
Hassall, C. H., Computer graphics as an aid to drug design. Chem. Britain.1 (1985) 39–46.
Henderson, R., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., and Downing, K. H., Model for the structure of bacteriorhodopsin based on high-resolution electron-cryomicroscopy. J. molec. Biol.213 (1990) 899–929.
Hitchings, G., Selective inhibitors of dihydrofolate reductase. In vitro Cell Dev. Biol.25 (1989) 303–310.
James, M. N. G., Sielecki, A., Salituro, F., Rich, D. H., and Hofmann, T., Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillipepsin. Proc. natl Acad. Sci. USA79 (1982) 6137–6141.
Janin, J., and Chothia, C., The structure of protein-protein recognition sites. J. biol. Chem.25 (1990) 16027–16030.
Karuso, P., Kessler, H., and Mierke, D. F., Solution structure of FK506 from nuclear magnetic resonance and molecular dynamics. J. Am. chem. Soc.112 (1990) 9434–9436.
Kilne, A. D., Braun, W., and Wüthrich, K., Studies by1H Nuclear magnetic resonance and distance geometry of the solution conformation of the α-amylase inhibitor tendamistat. J. molec. Biol.189 (1986) 377–382.
Kline, A. D., Braun, W., and Wüthrich, K., Determination of the complete three-dimensional structure of the α-amylase inhibitor tendamistat in aqueous solution by nuclear magnetic resonance and distance geometry. J. molec. Biol.204 (1988) 675–724.
Kollman, P. A., X-Ray Crystallography and Drug Action, chapt. 4, pp. 63–82. Eds A. S. Horn and C. J. D. Ranter. Oxford Univ. Press, 1984.
Kuyper, L. F., The potential role of solvation in the dihydrofolate reductase species selectivity of trimethoprim, in: Crystallographic and Modelling Methods in Molecular Design, pp. 56–79. Eds C. E. Bugg and S. E. Ealick. Springer-Verlag, Heidelberg 1989.
Lim, L. W., Stegemen, R. A., Leimgruber, N. K., Gierse, J. K., and Abdel-Meguid, S. S., Preliminary crystallographic study of glycolated recombinant human renin. J. molec. Biol.210 (1989) 239–240.
Loosli, H.-R., Kessler, H., Oschkinaf, H., Weber, H.-P., Petcher, J., and Widmer, A., The conformation of cyclosporin in the crystal and in solution. Helv. chim. Acta68 (1985) 682–704.
McCammon, J. A., Computer aided molecular design. Science238 (1987) 486–491.
Matthews, S. A., Bolin, J. T., Burridge, J. M., Filman, D. J., Volz, K. W., Kaufman, B. T., Beddell, C. R., Chapness, J. N., Stammers, D. K., & Kraut, J., Refined crystal structure of E. coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J. biol. Chem.260 (1985) 381–391.
Miller, S., The structure of interfaces between subunits of dimetric and tetrameric proteins. Protein Engng3 (1989) 77–83.
Miller, S., Jaskolski, M., Rao, J. K. M., Leis, J., and Wlodowar, A., Crystal structure of retroviral protease proves relationship to aspartic protease family. Nature337 (1989) 576–579.
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H., and Wlodowar, A., Struture of a complex of synthetic HIV-1 protease with a substrate based inhibitor at 2.3 Å resolution. Science246 (1989) 1149–1152.
Navia, M. A., McKeever, B. B., Springer, J. P., Lin, T-S., Williams, H. R., Firestone, R. A., Pisano, J. M., Docherty, J. B., Finke, P. E., and Hoogsteen, K., Crystallographic study of a beta lactam inhibitor complex with elastase at 1.84 Å. Nature327 (1987) 79–82.
Navia, M. A., McKeever, B. B., Springer, J. P., Lin, T.-S., Williams, H. R., Fluder, E. M., Dorn, C. P., and Hoogsteen, K., Structure of a human neutrophil elastase with a peptide chloromethyl ketone inhibitor at 1.84 Å. Proc. natl Acad. Sci. USA86 (1989) 7–11.
Oefner, C., D'Arcy, A., and Winkler, F. K., Crystal structure of human dihydrofolate reductase complexed with folate. Eur. J. Biochem.174 (1988) 377–385.
Osguthorpe, P. D., Roberts, V. A., Osguthorpe, D. J., Wolff, J., Genest, M., and Hagler, A. T., Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug receptor system. Proteins4 (1988) 31–47.
Pearlman, D. A., and Kollman, P. A., Free energy perturbation calculations: Problems and pitfalls along the gilded road, in: Computer Simulations of Bimolecular Systems and Experimental Applications, pp. 101–119. Eds. W. F. van Gunsteren and P. K. Weiner. ESCOM, 1989.
Pearl, Lh., and Taylor, W. R., A structural model for the retroviral protease. Nature329 (1987) 351–354.
Perutz, M. F., Electrostatic effects in proteins. Science201 (1978) 1187–1191.
Perutz, M. F., Fermi, G., Abraham, D. J., Poyart, C., and Bursaux, E., Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding. J. Am. chem. Soc.108 (1986) 1064–1078.
Perutz, M. F., Kendrew, J. C., and Watson, H. C., Structure and function of hemoglobin. J. molec. Biol.13 (1965) 669–678.
Popular programs distributed by QCPE, include AMPAC (506) and MOPAC (455), Quantum Chemistry Program Exchange (QCPE), Indiana University Chemistry Department.
Powers, J. C., Oleksyszyn, J., Narasimhan, S. L., Kam, C. M., Radhakrishnan, R., and Meyer, F. J., Reaction of porcine pancreatic elastase with 7-substituted 3-alkoxy-4-chloroisocoumarins: design of potent inhibitors using the crystal structure of the complex formed with 4-chloro-3-ethoxy-7-guanidoisocoumarin. Biochemistry29 (1990) 3108–3118.
Pullman, B., Lavery, R., and Pullman, A., Two aspects of DNA polymorphism and microheterogenecity: Molecular electrostatic popolymorphism and steric accessibility. Eur. J. Biochem.124 (1982) 229–238.
Richards, G., Quantum mechanics in molecular design, in: Computer-Aided Molecular Design, chapt. 3, pp. 43–50, IBC. 1989.
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H.-J., Johnson, J. E., Kramer, G., Luo, M., Moser, A. G., Ruecker, R. R., Sherry, B., and Vriend, G., Structure of human common cold virus and functional relationship to other piconaviruses. Nature317 (1985) 145–153.
Rydel, T. J., Ravichandran, K. G., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., and Fenton, J. I. I., The structure of a complex of recombinant hirudin and human α-thrombin. Science249 (1990) 277–280.
Schechter, I., and Berger, A., On the size of the active site in proteins. 1. Papain. Biochem. biophys. Res. Commun.27 (1967) 157–162.
Sheridan, R. P., and Allen, L. C., The active site electrostatic potential of human carbonic anhydrase. J. Am. chem. soc.103 (1981) 1544–1550.
Sielecki, A. R., Hayakawa, K., Fujinaga, M., Murphy, M. E. P., Fraser, M., Muir, A. K., Carilli, C. T., Lewicki, J. A., Baxter, J. D., and James, M. N. G., Structure of recombinant human renin, a target for cardiovascular-active drugs at 2.5 Å resolution. Science243 (1989) 1346–1351.
Stammers, D. K., Chapness, J. N., Beddell, C. R., Dann, J. G., Elipouslos, E., Geddes, A. J., Ogg, D., and North, A. C. T., The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of the human enzyme. FEBS218 (1987) 178–184.
Stout, G. H., and Jensen, L. H., X-Ray Structure Determination. A Practical Guide. John Wiley & Sons, New York 1989.
Takahashi, L. H., Radhakrishnan, R., Rosenfeld, R. E., Meyer, E. F., and Trainor, D. A. Crystal structure of the covalent complex formed by a peptidyl alpha-alpha-difluoro-ketone amide with porcine pancreatic elastase at 1.78 Å. J. Am. chem. Soc.111 (1989) 3368–3374.
Vedani, A., and Huhta, D. W., A new force field for modeling metalloproteins. J. Am. chem. Soc.112 (1990) 4759–4767.
Walkinshaw, M. D., Protein targets for structure based drug design. Med. Res. Rev. (1991) in press.
Warshel, A., and Levitt, M., Theoretical study of lysozyme catalysis. J. molec. Biol.103 (1976) 227–249.
Weber, Ch., Widmer, G., von Freyberg, B., Traber, R., Braun, W., Widmer, H., and Würthrich, K., The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. Biochemistry30 (1991) 6563–6574.
Weber, P. C., Ohlendorf, Wendoloski, J. J., and Salemme, F. R., Structural origins of high-affinity binding to streptavidin. Science243 (1989) 85–88.
Widmer, H., and Breckenridge, R., Conformation and mobility of calcitonin studies by NMR and restrained molecular dynamics calculations. Proc. XIV Int. Conference NMR, p. 8. ICMRBS, Warwick, 1990.
Weiner, P. K., and Kollman, P. A., AMBER: assisted model building with energy refinement. A general program for modeling molecules and their interactions. J. Comp. Chem.2 (1981) 287–303.
Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Profeta, S., and Weiner, P. J., A new force field for molecular mechanics simulation of nucleic acids and proteins. J. Am. chem. Soc.106 (1984) 765–784.
Weiner, P. K., Langridge, R., Blaney, J. M., Shaefer, R., and Kollman, P. A., Electrostatic potential surfaces. Proc. natl Acad. Sci. USA79 (1982) 3754–3758.
White, D. N., Ruddock, J. N., and Edington, P. R., Molecular mechanics, in: Computer-Aided Molecular Design, chapt. 2, pp. 23–41. IBC, 1989.
Wlodowar, A., Miller, M., Jaskolski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., and Keny, S. B. H., Conserved folding in retroviral proteases: Crystal structure of synthetic HIV-1 protease. Science245 (1989) 616–621.
Wong, C. F., and McCammon, J. A., Dynamics and design of enzymes and inhibitors. J. Am. chem. Soc.108 (1986) 3830–3832.
Wright, P. E., What can two-dimensional NMR tell us about proteins? Trends biochem. Sci.14 (1989) 255–260.
Wüthrich, K., NMR of Proteins and Nucleic Acids. John Wiley & Sons, New York 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breckenridge, R.J. Molecular recognition: Models for drug design. Experientia 47, 1148–1161 (1991). https://doi.org/10.1007/BF01918379
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01918379